Moderators: C. Wright Pinson, MD, MBA, H. Wm. Scott Professor of Surgery,
Associate Vice-Chancellor for Clinical Affairs, Chief Medical Officer, Vanderbilt University Medical Center

Carols Chan, M.D., Assistant Professor of Surgery, Instituto Nacional de la Nutricion, Mexico

Quality, safety, and costs as the primary drivers for care from the patient, hospital and payer’s perspective.
Speaker: Ravi Chari, M.D., MBA, Professor of Surgery, Vanderbilt University, Chief Medical Officer, Centennial Medical Center, TriStar Division, HCA

Affordable care, not quality and outcomes will accelerate HPB Surgical tourism in the Americas.
Speaker: Scott Helton, M.D., Chair of Surgery,
Hospital of Saint Raphael, New Haven, CT

Improving HPB Care in Rural America: From the Artic to Tierra del Fuego: The conundrum between Regionalized and Decentralized care.

Moderators: Sean Mulvihill, M.D., Chair of Surgery, University of Utah

Nèstor A. Gòmez, MD., FACS, Professor of Surgery, State University of Guayaquil, Ecuador

Canadian Perspective
Speaker: Elijah Dixon, MD. Assistant Professor of Surgery,
University of Calgary, Alberta, Canada

The U.S. Crisis in Access to Care
Speaker: Randal Zukerman, MD.
Hospital of Saint Raphael, New Haven, CT

The South American Perspective:
Speaker: Edmundo Machado Ferraz, M.D. PhD, FACS
Professor and Chairman, University Hospital Recife - Brazil
President, Brazilian College of Surgeons

Postgraduate Course

Session III.
Innovation in Liver-directed Therapy

Moderators and Introduction
Clark Gamblin, M.D., Assistant Professor of Surgery, University of Pittsburgh Liver Cancer Center

Oscar Claudio Andriani, M.D., Associate Director of the Hepatobiliary Surgery and Liver Transplant Hospital Universitario Austral, Buenas Aires, Argentina

Innovation in HPB Education and training
Speaker: Mika Sinanan, M.D., PhD, Professor of Surgery, University of Washington, Seattle, Wa

Overview of International Consensus Conference on Laparoscopic Liver Surgery.
Speaker: Joseph Buell, M.D., Professor of Surgery, Chief of Transplantation, University of Louisville, KY

Genomics and biologic indicators will predict who will and will not be candidates for specific HPB cancer therapies.
Speaker: Tim Pawlik, M.D., Associate Professor of Surgery and Oncology Department of Surgery Johns Hopkins University,

Bipolar RFA and Electroporation
Speaker: Joseph Espat, M.D., Professor of Surgery, Boston University, Director Roger Williams Cancer Center, Providence RI

Microwave ablation technologies
Speaker: David Iannitti, M.D., Director of HPB Surgery,
Carolinas Medical Center

Cyber knife for HPB malignancy
Speaker: Robert Goldstein, M.D., Professor of Surgery and Transplantation, Baylor University, Dallas TX.

Discussion

DVD 4 … U$ … 50.00

Postgraduate Course

Session VI.
Innovation in Pancreatic/Biliary Therapies

Moderators:
Juan Sarmiento, M.D., Assistant Professor of Surgery,
Emory University, Atlanta Georgia

Juan Pekolj, M.D, Professor of Surgery, Director of HPB Surgery, Hospital Italiano, Buenas Aires, Argentina.

Innovative solutions to prevent Pancreatic fistulas
Speaker: Bill Hawkins, Assistant Professor of Surgery,
Washington University, St. Louis, MO

MIS necrosectomy and beyond
Speaker: John Windsor, M.D., Professor of Surgery,
Chair Department of Surgery, Aukland University, Aukland NZ

MIS pancreatic surgery is here to stay:
Speaker: Horacio J. Asbun, M.D., Director, Hepatobiliary and Pancreas Surgery Mayo Clinic Florida, Jacksonville, FL

Incision free HPB Surgery with Microrobots
Speaker: To be announced.

Closing Discussion

1 - Second hepatic resection for recurrent hepatocellular carcinoma
Sasan Roayaie, MD, Domenico Bassi, Spiros Hiotis, MD, Daniel Labow, MD, Myron Schwartz, MD, Mount Sinai Hospital, New York, NY.

2 - Incorporating an HPB fellowship does not diminish surgical residents' HPB experience in a high-volume training program
Nicholas J Zyromski, MD, Laura Torbeck, PhD, David F Canal, MD, Keith D Lillemoe, MD, Henry A Pitt, MD, Indiana University, Indianapolis, IN.

3 - Improved Survival with Aggressive Resection of Hilar Cholangiocarcinoma
Yee Lee Cheah, MD, Mohamed Akoad, MD, Khashayar Vakili, MD, James J Pomposelli, MD, PhD, Elizabeth A Pomfret, MD, PhD, W David Lewis, MD,
Roger L Jenkins, MD, Lahey Clinic, Burlington, MA.

4 - Validation of a Predictive Algorithm to Maximize Resectability of Pancreatic Adenocarcinoma
Philip Bao, MD, Douglas Potter, PhD, Jennifer Young, David Eisenberg, MD, Diana Lenzner, MS, Kenneth Lee, MD, Herbert Zeh, MD, Michael Sanders,
MD, Steven Hughes, MD, A. James Moser, MD, University of Pittsburgh, Pittsburgh, PA; UPCI Biostatistics Facility, Pittsburgh, PA.

5 - Serial Molecular Analysis Of Eus Guided Fna Aspiration Of Pancreatic Cysts: Quantitative Molecular Evidence Detects Neoplastic Cyst
Progression, Stability Or Regression
Damien Mallat, MD, John P Tazelaar, Christine Spence, PhD, Elaine M Elder, ScD, Sydney D Finkelstein, MD, Baylor University, Dallas, TX; RedPath
Integrated Pathology, Pittsburgh, PA.

6 - A Simple Risk Score Predicts Inpatient Mortality after Liver Resection for Hepatocellular Carcinoma
Jessica P Simons, MD, Sing Chau Ng, MS, Joshua S Hill, MD, Shimul A Shah, MD, Zheng Zhou, MD, PhD, Jennifer F Tseng, MD, MPH, University of
Massachusetts Medical School, Worcester, MA.

7 - SNPs IN RecQL Predict Survival In Pancreatic Adenocarcinoma
Marie-claude Gingras, PhD, Donghui Li, PhD, Sally Elizabeth Hodges, Richard A Gibbs, PhD, F Charles Brunicardi, MD, William E Fisher, MD, Baylor, College of Medicine, Houston, TX; M. D. Anderson Cancer Center, Houston, TX.

8 - Biliary Complications including a Single Donor Mortality: Experience of 207 Adult-to-Adult Living Donor Liver Transplantation.
Mahmoud A El-meteini, MD, Alaa F Hamza, MD, Amr A Abdalaal, MD, Mohamed F. Fathy, MD, Mohamed Bahaa, MD, Ahmed Mokhtar, MD, Fawzia
Abouelfetouh, MD, Ibrahim Mostafa, MD, Ahmed El-dorry, MD, Ain-Shams University, Cairo, Egypt; Wady ElNeel Hospital, Cairo, Egypt

1. Introduction of the President
2. Presidential Address

Mark P. Callery
Harvard Medical School

DVD 7 … U$... 50.00

SYMPOSIUM

Current Management Strategies of Complicated Pancreatitis
- Imaging in Acute and Chronic Pancreatitis
Vamsi Narra

- Surgical Techniques and Management
Rowan Parks

- Endoscopic Approaches
Gary Vitale

- Role of Percutaneous/Laparoscopic Intervention
Hein Gooszen

- Total Pancreatectomy with Autotransplantation
– What is the Role?
John Christein

Management of complex pancreatitis remains a challenge throughout the world. This symposium brings together experts to discuss therapeutic advances and the current state-of-the-art for acute and chronic pancreatitis.

SYMPOSIUM

The Changing Paradigm of Metastatic Colorectal Cancer
Moderator: Anton Bilchik, MD

- Management of the “Disappearing” Colorectal Liver
Metastases: Resect or Wait?
Yuman Fong

- Neoadjuvant Therapy and Staged Resections – Do
They Really Work and What is the Downside?
Rene Adam

- Chemotherapy Induced Hepatoxicity: Work-Up and
Therapeutic Strategies
Nick Vauthey

- Liver Resection in the Face of Extrahepatic Disease
When is it Indicated?
Mike Choti

Liver metastases remain the most common site of the spread of colorectal cancer. New therapeutic strategies including improved chemotherapy have enhanced treatment options and challenged traditional management approaches.

IHPBA Editorial Member Meeting
IHPBA Membership Meeting

DVD 10 … U$ 50.00

State of the Art Lecture
Staging of Acute Pancreatitis
International Speaker: Hein Gooszen
Utrecht, Netherlands

State of the Art Lecture
Nanotechnology – What is the Future?
International Speaker: Mike Mason
Bar Harbor, ME

DVD 11 … U$ 50.00

President’s Invited Speaker
In the Kingdom of the Blind, the One-eyed are King
Speaker: Josef E. Fischer, MD
Harvard Medical School

SPECIAL DEBATE 1

Transplantation for Early Stage HCC Versus Other Therapeutic
Approaches
Debate: Transplantation is the gold standard vs.
Surgical resection and ablation should be the initial preferred approach

Ronnie Poon vs Nancy Ascher
“Surgical Resection and Ablation Provides Satisfactory Long-Term Results for the Majority of Patients and Should be the Preferred Initial Approach” Poon

"Liver Transplantation is the Best Approach to Provoide the Optimal Long-Term Search" Ascher

Rebuttal/Discussion
The approach and management for hepatocellular carcinoma varies widely within the world and even within the United States. This debate will be centered around the following question: Should liver transplantation be the preferred treatment strategy for Child’s A cirrhotic patients with small HCC or
should other therapeutic strategies including hepatic resection and ablative therapy be utilized with consideration of transplantation only on a highly selective basis?

SPECIAL DEBATE 2

HAI Therapy for Colorectal Metastases – Is There a Role?

Debate: Pump chemotherapy has an excellent track record vs. Systematic chemotherapy will suffice in almost all patients

Nancy Kemeny vs Jordan Berlin
“HAI therapy produces superior results to standard systemic chemotherapy for hepatic colorectal metastases.” Kemeny

“HAI therapy has a high technical failure rate and is unnecessary except in highly selected cases.” Berlin

Rebuttal/Discussion
There is significant controversy regarding the role of regional chemotherapy and management of metastatic colorectal cancer. This session will feature a presentation of relevant data regarding the differing strategies for treatment of hepatic metastases from colorectal carcinoma.

9 - Surgical Downstaging and Neo-adjuvant Therapy in Metastatic Colorectal Carcinoma with Irinotecan Drug Eluting Beads: A Multi-Institutional Study
Matthew Bower, MD, Ken Robbins, MD, Dana Tomalty, MD, Charles R. Scoggins, MD, Kelly M Mcmasters, MD, PhD, Robert Cg Martin, MD, University
of Louisville, Louisville, KY; Baptist Health, Little Rock, AR; Huntsville Hospital, Huntsville, AL

10 - Exsanguination Protocol Improves Survival after Major Hepatic Trauma
Victor Zaydfudim, MD, William D. Dutton, MD, Irene D. Feurer, PhD, Brigham K. Au, B.Sc., C. Wright Pinson, MD, MBA, Bryan A. Cotton, MD, Vanderbilt
University Medical Center, Nashville, TN.

11 - Evaluation of perioperative chemotherapy using a prognostic nomogram for survival following resection of colorectal liver metastases
Srinevas K Reddy, MD, Micheal W Kattan, PhD, Changhong Yu, PhD, Eugene P Ceppa, MD, Sebastian G De La Fuente, MD, Yuman Fong, MD, Bryan
M Clary, MD, Rebekah R White, MD, Duke University Medical Center, Durham, NC; Cleveland Clinic, Cleveland, OH; Memorial Sloan Kettering Cancer
Center, New York, NY.

12 - Hepatectomy after Neoadjuvant Chemotherapy for Initially Unresectable Liver Metastases from Colorectal Cancer
Joseph Raccuia, MD, Justin Steele, MD, Igor Nichiporenko, MD, Saint Vincent's Hospital Manhattan, New York, NY.

13 - Resection of colorectal cancer (CRC) liver metastases: What is an adequate margin?
Robert T Padbury, MD, PhD, Dries Vandeweyer, MBBS, Guy J Maddern, MD, PhD, John W Chen, MD, PhD, Flinders Medical Centre, Adelaide,
Australia; The Queen Elizabeth Hospital, Adelaide, Australia.

14 - Locally Advanced Intrahepatic Cholangiocarcinoma: Survival Benefit with Aggressive Hepatic Resection
Swee H Teh, MD, Dan Cusati, MD, Jayleen Grams, MD, Edward Aboian, MD, Lin Chang, MD, Steve Cha, PhD, Larry Burgart, MD, David M Nagorney,
MD, Sacred Heart Medical Center, Eugene, OR; Mayo Clinic, Rochester, MN; Mayo Clinic, Rochester, MN.

15 - Long-term outcome following sequential resections of liver and lung metastases from colorectal carcinoma
Ravi Marudanayagam, MS, Ramkumar Krishnamoorthy, MS, Vivek Shanmugam, MS, Chris Coldham, None, Simon Bramhall, MD, MBBS, David Mayer, MD, MBBS, John Buckels, MD, MBBS, Darius Mirza, MS, Queen Elizabeth Hospital, Birmingham, U.K., Birmingham, United Kingdom.

16 - Predictors Of Blood Transfusion Requirement In Elective Liver Resection
Andrew J Cockbain, MBBS, Tahir Masudi, MBBS, Giles J Toogood, MD, J Peter Lodge, MD, K Raj Prasad, MD, St James' University Hospital, Leeds,
United Kingdom.

17 - Targeting Focal Adhesion Kinase inhibits Pancreatic Cancer Growth and Metastasis
Jayme B. Stokes, MD, Robert W. Tilghman, PhD, E. Dan Hershey, MS, Jill K. Slack-davis, PhD, J. Thomas Parsons, PhD, Todd W. Bauer, MD,
University of Virginia, Charlottesville, VA.

18 - The molecular mechanism of HIF-1independent VEGF expressionin hepatocellular carcinoma cell line
Sae Byeol Choi, MD, Jong Bae Park, PhD, Kyung Sik Kim, MD, PhD, Taejin J Song, MD, PhD, Yonsei University College of Medicine, Seoul, Republic
of Korea; Research Institute and Hospital, National Cancer Center, Ilsan, Republic of Korea; Korea University College of Medicine, Ansan, Republic of
Korea.

19 - Proteasome Inhibition in Combination Therapy of Experimental Pancreatic Cancer: In Vitro and In Vivo Evaluation
Niranjan Awasthi, PhD, Margaret A Schwarz, MD, Roderich E Schwarz, MD, UT Southwestern Medical Center, Dallas, TX.

20 - Anti-Inflammatory Effects of the Nigella Sativa Seed Extract, Thymoquinone, In Pancreatic Cancer Cells
Hwyda A. Arafat, MD, PhD, Navdeep Chehl, B.Sc., Galina Chipitsyna, PhD, Qioake Gong, MD, Charles J. Yeo, MD, Thomas Jefferson Univesity,
Philadelphia, PA.

21 - A proteomic based platform for marker discovery in Cholangiocarcinoma
Glenn K Bonney, Rachel Craven, Alan Melcher, Peter Selby, Rosamonde Banks, Raj Prasad, St James' University Hospital, Leeds, United Kingdom.

22 - Microenvironment-induced gene expression changes in breast cancer liver metastases
SÈbastien TabariËs, PhD, Zhifeng Dong, MD, Francois PÈpin, Michael Hallett, PhD, Atilla Omerglu, MD, Mazen Hassanain, MD, Peter Metrakos, MD,
Peter M Siegel, PhD, McGill University, Montreal, QC, Canada.

23 - Validation of a Novel, Physiologic Model of Experimental Acute Pancreatitis in the Mouse
Nicholas J Zyromski, MD, Terrence E Wade, MD, Henry A Pitt, MD, Sue Wang, MD, Deborah A Swartz-basile, PhD, Indiana University, Indianapolis, IN.

24 - The Expression of Interferon Receptor Alpha/Beta in Human Pancreatic Cancer in Nude Mice is Essential for Tumor Response to Interferon Alpha Treatment
Reza F Saidi, MD, Ahmad W Ahad, MD, Ilke Nalbantoglu, MD, Michael J Jacobs, MD, Massachusetts General Hospital, Boston, MA; Providence
Hospital, Southfield, MI; Department of Pathology, St John Hospital, Detroit, MI; Departmen of Surgery, Providence Hospital, Southfield, MI.

SYMPOSIUM
Pancreas Case Presentations With the Experts
Moderator: Keith Lillemoe

Panelists:
Rick Schulick
David Adams
Rowan Parks
Mike Farnell
Carlos Chan

In this session, recognized experts in the management of benign and malignant diseases of the pancreas will provide their opinions regarding optimal management strategies for challenging cases. This session will include audience participation with electronic polling and immediate
presentation of the audience and experts’ opinions regarding optimal management.

DVD 18 … U$ … 50.00

SYMPOSIUM

Ethical Issues in Liver Transplantation
- Use of marginal donors in low MELD recipients
– how do we inform recipients?
Joe Tector

- Living donation in adult liver transplantation
Igal Kam
- Liver organ allocation – what’s on the horizon?
Elizabeth Pomfret
- The transplant center perspective – how to drive volume while controlling quality
Marwan Abouljoud

Liver transplantation has become standard therapy for many recognized diseases and excellent outcomes are now the norm for most patients. However, many controversial issues exist regarding patient selection and organ allocation. This session will bring together a panel of experts to discuss these challenging ethical dilemmas.

25 - Is the Use of Donors with High Donor Risk Indices Cost-Effective in Liver Transplantation?
Derek E Moore, MD, MPH, Irene Feurer, PhD, C. Wright Pinson, MD, MBA, Vanderbilt University, Nashville, TN.

26 - The Development of a Classification System for Biliary Complications Following Orthotopic Liver Transplantation
Amy Neville, MD, Marylise Boutros, MD, Jeffrey Barkun, MD, Royal Victoria Hospital, McGill University, Montreal, QC, Canada.

27 - Regionalization of Liver Transplantation to High Volume Centers Is Associated with Diminished Volume-Outcomes Relationship and
Underutilization of High Volume Centers By Minority Patients.
Elisabeth T Tracy, MD, Emiline M Aviki, Theodore N Pappas, MD, Bradley H Collins, MD, Janet E Tuttle-newhall, MD, Carlos E Marroquin, MD, Paul C
Kuo, MD, John E Scarborough, MD, Duke University, Durham, NC.

28 - Is Magnetic Resonance Imaging Superior to Computed Tomography for Preoperative Evaluation of Cystic Lesions of the Pancreas?
Carrie K. Chu, MD, Ashley E. Mazo, B.Sc., Charles A. Staley, MD, Juan M. Sarmiento, MD, Diego R. Martin, MD, William E. Torres, MD, N. Volkan
Adsay, MD, David A. Kooby, MD, Emory University School of Medicine, Atlanta, GA.

29 - Comparative Performance of Staging Systems for Early Hepatocellular Carcinoma
Hari Nathan, Gilles Mentha, Hugo P Marques, Lorenzo Capussotti, Pietro Majno, Luca Aldrighetti, Carlo Pulitano, Laura Rubbia-brandt, Nadia Russolillo, Benjamin Philosophe, Eduardo Barroso, Alessandro Ferrero, Michael A Choti, Timothy M Pawlik, The Johns Hopkins University, Baltimore, MD.
30 - Liver Retransplantation - A 25 Year Experience
Vivekanandan Shanmugam, Chandrasekar Bhati, Ravi Maruthanayagam, John Buckels, Darius F Mirza, Simon R Bramhall, Queen Elizabeth Hospital,
Birmingham, United Kingdom.

31 - Initial experience using Hepatitis C positive renal allografts in elderly Hepatitis C negative recipients
Tanya R Flohr, MD, Douglas Keith, MD, Peter I Lobo, MD, Brian R Swenson, MD, Hugo Bonatti, MD, Timothy M Schmitt, MD, Robert G Sawyer, MD,
Timothy L Pruett, MD, Kenneth L Brayman, MD, PhD, University of Virginia, Charlottesville, VA.

32 - Repair of Laparoscopic Bile Duct Injuries: Timing of Surgical Repair does not Influence Success Rate.
Lygia Stewart, MD, Lawrence W. Way, MD, UCSF, San Francisco, CA.

33 - Role of Preoperative Biliary Drainage of Liver Remnant Prior to Extended Liver Resection for Hilar Cholangiocarcinoma
Timothy J Kennedy, MD, Adam Yopp, MD, Larry Schwartz, MD, Yilin Qin, MS, Pingzhen Guo, MD, Binsheng Zao, ScD, Michael D'angelica, MD, Yuman
Fong, MD, Peter Allen, MD, Ronald Dematteo, MD, Leslie H Blumgart, MD, William R Jarnagin, MD, Memorial Sloan Kettering Cancer Center, New
York, NY.

34 - Elevated CA 19-9 Portends Poor Prognosis despite Surgical Resection of Biliary Malignancies
Ioannis Hatzaras, MD, Carl R Schmidt, MD, Peter Muscarella, MD, W Scott Melvin, MD, E Christopher Ellison, MD, Mark Bloomston, MD, Ohio State
University, Columbus, OH.

35 - Identification of Intraductal Papillary Mucinous Neoplasm in Resected Biliary Tract Lesions
Joshua G Barton, MD, David Barrett, MD, Marco Maricevich, MD, Christina Wood, MS, Thomas Smyrk, MD, David Nagorney, MD, Todd Baron, MD,
Florencia Que, MD, Mayo Clinic, Rochester, MN.

36 - Iatrogenic Bile Ductinjury With Loss Of Confluence:A Surgical Challenge
Miguel Angel Mercado, MD, Norberto Sanchez, MD, Juan Carlos Arriola, MD, Miguel Urencio, MD, Sofia Sanchez-leenheer, MD, Ismael Dominguez,
MD, Instituto Nacional de la NutriciÛn Salvador Zubir·n, Mexico City, Mexico.

37 - Helicobacter spp. in gallbladder tissue of patients with symptomatic gallbladder disease
Shirin Sabbaghian, MD, Jeffrey Ranaudo, MD, Lin Zeng, MD, Alexandra Alongi, B.Sc., Guillermo Perez-perez, ScD, Peter Shamamian, MD, New York
University School of Medicine, New York, NY.

38 - What is the benefit of radical resection for T1b gallbladder cancer: a decision analysis
Michael A Abramson, MD, Daniel Ruan, MD, Edward E. Whang, MD, Brigham and Women's Hospital, Boston, MA.

39 - Epidemiologic Differences On Presentation Of Gallbladder Cancer Between A High-Risk (Temuco, Chile) And A Low-Risk Population
(Georgia, USA); Not All Cancers Are Created Equal.
Hector Losada, MD, Maribel Munoz, MD, Gabriela Velasquez, MD, Andrew Page, MD, Juan Carlos Roa, MD, David Kooby, MD, John Galloway, MD,
Charles Staley, MD, Volkan Adsay, MD, Juan M Sarmiento, MD, Universidad de la Frontera, Temuco, Chile; Emory University, Atlanta, GA.

40 - The Role Of PET-CT In Patients With Incidental Gallbladder Cancer
Jean M Butte, Md, Francisca Redondo, Md, Enrique Waugh, Md, Manuel Meneses, Md, Rossana Pruzzo, Md, Hugo Parada, Md, Horacio Amaral, Md,
Hernan A De La Fuente, Md, Fundacion Arturo Lopez Perez Cancer Center, Santiago, Chile; Fundacion Arturo Lopez Perez Cancer Center, Santiago,
Chile.

Imaging Primary Malignancies of the Liver Vamsidha Narra
Imaging the IPMN Spectrum Lawrence Schwartz
Molecular Imaging in Hepatobiliary Disease Timothy Akhurst

Monitoring Response to Local Therapies David Grand
Improvements in imaging continue at a rapid rate and profoundly influence the practice of HPB surgery.

DVD 22 … U$ … 50.00

41 - Hpb Nsqip: Potential For Quality Improvement, Registries, And Clinical Trials
Henry A Pitt, MD, Molly Kilbane, RN, BSN, Nicholas J. Zyromski, MD, Thomas A. Aloia, MD, J. Michael Henderson, MD, Sean J. Mulvihill, MD, Indiana
University, Indianapolis, IN; The Methodist Hospital, Houston, TX; Cleveland Clinic, Cleveland, OH; University of Utah, Salt Lake City, UT.

42 - Clinical Factors Predictive of Malignant and Premalignant Cystic Neoplasms of the Pancreas
Natalie B Jones, MD, E. Christopher Ellison, MD, W. Scott Melvin, MD, Peter Muscarella, MD, Mark Bloomston, MD, The Ohio State University,
Columbus, OH.

43 - Escalating Computed Tomography Angiogram (CTA) Grade Predicts Unresectability and Positive Margins For Pancreaticobiliary
Neoplasms
Tara S Kent, MD, Alphonso Brown, MD, Mark P Callery, MD, Vassilios D Raptopoulos, MD, Charles M Vollmer, MD, Beth Israel Deaconess Medical
Center, Boston, MA.

44 - Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreas
cancer
Rebecca J Mcclaine, MD, Andrew M Lowy, MD, Jeffrey J Sussman, MD, Faheem Ahmed, MD, Nathan Schmulewitz, MD, David Grisell, MD, Michael J
Edwards, MD, Syed A Ahmad, MD, University of Cincinnati, Cincinnati, OH.

45 - Multimodal therapy for treatment of hepatocellular carcinoma: A ten-year survival analysis.
Andrew Schumacher, MD, James Powell, MD, Andrzej Buczkowski, MD, Charles Scudamore, MD, Stephen Ho, MD, Stephen Chung, MD, PhD,
University of British Columbia, Vancouver, BC, Canada; Royal Infirmary of Edinburgh, Edinbugh, United Kingdom.

46 - Results Of Total Pancreatectomy: A Single Center Experience
John Stauffer, MD, C. Dan Smith, MD, J. Kirk Martin, MD, Justin Nguyen, MD, Mayo Clinic, Jacksonville, FL.

47 - Predicting Poor Outcome Following Hepatectomy: Analysis of 2,313 Hepatectomies in the NSQIP Database
Thomas A Aloia, MD, Bridget N Fahy, Craig P Fischer, MD, Stephen L Jones, MD, Andrea Duchini, MD, Joseph Galati, MD, A O Gaber, MD, Barbara L
Bass, MD, R Mark Ghobrial, MD, PhD, The Methodist Hospital, Houston, TX.

48 - Validation Of The Meld Based Objective Scoring System (Moss): Unresectable Hepatocellular Carcinoma In Patients With Cirrhosis
Swee H Teh, Chet Hammill, MD, Linda Wong, MD, Brett Sheppard, MD, Jonathan Schwartz, MD, Kaufman John, MD, Ken Kolbeck, MD, Steve Cha,
PhD, Susan Orloff, MD, Sacred Heart Medical Center, Eugene, OR; University of Hawaii, Honolulu, HI; Oregon Health Sciences University, Portland,
OR; Mayo Clinic, Rochester, MN.

48a - Interpreting three-dimensional structures from two-dimensional images: a web-based interactive 3D model of the liver to enhance
surgical residents; spatial understanding of structural inter-relationships
Jodi Crossingham, B.Sc., Jodie Jenkinson, Nick Woolridge, Steven Gallinger, MD, Carol-anne Moulton, MD, Toronto General Hospital, Toronto, ON,
Canada; University of Toronto, Toronto, ON, Canada.

49 - Surgery Residency Training Programs Greatly Impact Outcomes After Pancreaticoduodenectomy, Greater Than Hospital Volume Or Surgeon Frequency
Alexander S. Rosemurgy, MD, Bri Anne Mckeon, B.Sc., Alyssa Kahn, Connor A. Morton, B.Sc., Paul Toomey, MD, Jonathan M. Hernandez, MD, Nitin
Babel, MD, Sharona B. Ross, MD, University of South Florida, Tampa, FL.

50 - Pyogenic Liver Abscess Following Pancreaticoduodenectomy: Risk Factors, Treatment, And Long-Term Outcome
Victor C. Njoku, MS, Nicholas J. Zyromski, MD, C. Max Schmidt, MD, PhD, Henry A. Pitt, MD, Attila Nakeeb, MD, Keith D. Lillemoe, MD, Thomas J.
Howard, MD, Indiana University School of Medicine, Indianapolis, IN.

51 - Admission Volume As a Determinant of Outcome For Patients With Acute Pancreatitis
Anand Singla, B.Sc., Jessica P Simons, MD, Sing Chau Ng, MS, James Hart, B.Sc., Jennifer F. Tseng, MD, Shimul A Shah, MD, University of
Massachusetts, Worcester, MA.

52 - Benign Pancreatic Islet Cell Tumors: Resect or Enucleate?
Susan C Pitt, MD, Henry A Pitt, MD, Marshall S Baker, MD, Sharon M Weber, MD, Stuart D Wilson, MD, Thomas J Howard, MD, Mark S Talamonti, MD,
Layton F Rikkers, MD, University of Wisconsin, Madison, WI; Indiana University, Indianapolis, IN; Northwestern University, Evanston, IL; Medical
College of Wisconsin, Milwaukee, WI; Evanston Northwestern Healthcare, Evanston, IL.

53 - Revision of anastomotic stenosis after pancreatic head resection for chronic pancreatitis: Is it futile?
Katherine Morgan, MD, Bennett Fontenot, MD, Suzanne Mickey, B.Sc., David Adams, MD, Medical University of South Carolina, Charleston, SC.

54 - Outcome Of Radical Vs Limited Pancreratic Head Resection For Chronic Pancreatitis - A Meta-Analysis
Nicole Tsim, MBBS, Adel Abulkhir, MD, P Limongelli, MD, Madava Pai, MD, Osama Damrah, MD, Natalie Johnson, MBBS, A Ayav, MD, Nagy A Habib,
None, Long R Jiao, MD, Imperial College, London, United Kingdom; University Hospital Nancy-Brabois, Vandoeuvre Les Nancy, France.

55 - A Simplified Prognostic System for Resected Pancreatic Neuroendocrine Neoplasms
Nikiforos Ballian, MD, Peter Norstedt, Agnes Loeffler, MD, Victoria Rajamanickam, PhD, Sharon M Weber, MD, Clifford S Cho, MD, University of
Wisconsin School of Medicine and Public Health, Madison, WI.

56 - Routine Intra-operative Biliary Cultures during Pancreaticoduodenectomy: a Guide to Avoid Postoperative Complications
Vedra A. Augenstein, MD, Nathan Reuter, MD, Kelly M Mcmasters, MD, Charles R Scoggins, MD, Robert C Martin, University of Louisville, Louisville,
KY.

57 - Pancreatic Resection: A Key Component to Reducing Racial Disparities in Pancreatic Adenocarcinoma
Melissa M Murphy, MD, MPH, Jessica P Simons, MD, Theodore P Mc Dade, MD, Zheng Zhou, MD, Lynn H Harrison Jr, MD, Jennifer F Tseng, MD,
MPH, University of Massachusetts Medical School, Worcester, MA.

INVITED VIDEO SESSION 1: LIVER
1. Gallbladder Cancer Resection – Bill Jarnagin
2. Living Donor Liver Resection and Implantation
– Marwan Abouljoud
3. Laparoscopic Right Hepatectomy – Daniel Cherqui
4. Liver Resection with Caval Resection and Reconstruction
– Alan Hemming

196 - Bilobar Totally Laparoscopic Anatomic Segmental Resection of Hepatocellular Carcinoma in Cirrhotics
Hisae Aoki, MD, Carlos Uriel Corvera, UCSF Department of Surgery, San Francisco, CA.

197 - Right Hepatectomy extended to Segment 4a for Hepatocellular Carcinoma
Daniel Cherqui, MD, Luca Vigano, MD, Alexis Laurent, MD, Claude Tayar, MD, Henri Mondor Hospital, Creteil, France.

198 - Hepatic Resection in Polycystic Liver Disease
Juan A Salceda, MD, Matias Nicolas, MD, Diego Lucas Fernandez, MD, Eduardo De Santibanes, MD, PhD, Juan Pekolj, MD, PhD, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

199 - Two-Stage Laparoscopic Liver Resection for Bilobar Colorectal Liver Metastasis
Marcel Autran Machado, MD, F·bio Ferrari Makdissi, MD, Rodrigo Canada Surjan, MD, Guilherme Kappaz, MD, Nagamassa Yamaguchi, MD, University
of Sao Paulo, Sao Paulo, Brazil.

200 - En-bloc Right Nephrectomy/Right Hepatectomy with Hanging Liver Technique
David A. Kooby, MD, Viraj Master, MD, PhD, Emory University, Atlanta, GA.

201 - Transabdominal And Intrapericardial Surgical Approach Without The Use Of Cardiopulmonary Bypass In The Management Of Retrohepatic And Supraphrenic Inferior Vena Cava Thrombus Extending Into Right Atrium
Emilio Vicente, MD, PhD, Yolanda Quijano, MD, PhD, Enrique Esteban, MD, Pablo Galindo, MD, Manuel Marcello, MD, Ramon Conradi, MD, Carmelo
Loinaz, MD, PhD, Hipolito Duran, MD, PhD, Juan A. Roman, MD, BegoÒa Morato, MD, Elena Garcia, MD, PhD, Hospital Madrid Norte Sanchinarro.
Universidad San Pablo. CEU. Facultad de Medicina, Madrid, Spain.

202 - Totally Laparoscopic Right Trisectionectomy Using Intrahepatic Glissonian Approach
Marcel Autran Machado, MD, Fabio Ferrari Makdissi, MD, Rodrigo Canada Surjan, MD, Andre Cosme Oliveira, MD, Victor Francisco Pilla, MD, Antonio
Roberto Teixeira, MD, University of Sao Paulo, S„o Paulo, Brazil.

203 - Robotic Resection of Colon Cancer Metastasis to the Caudate Lobe

Symposium

Emerging Image Guidance Systems for HPB Surgery
Moderator: David Iannitti

- US With Virtual-3D Interface – John Martinie
- Electromagnetic and Optical Tracking for Image Guidance in Liver Surgery
– Bill Jarnagin
- MR with Visual Optical Tracking – Forenc A. Jolesz
- GPS System for Needle Guidance – Damian Dupuy

Many emerging technologies involving liver image-assessment and-image planning are now underway. Experts in the new technology areas will discuss cutting edge advances in this session.